Nvidia, a leader in AI computing, continues to work with surgical robotic companies, following recent collaborations with the likes of Moon Surgical and Virtual Incision. Asensus Surgical linked up with Nvidia in 2023 to deliver novel clinical intelligence to surgeons in surgical robotics as well.
Stereotaxis says Nvidia’s GTC 2025 event this week is bringing together engineers, researchers and inventors to pioneer applications for AI. (We have a full roundup of medtech AI news out of Nvidia’s “Super Bowl of AI.”)
At the conference, Nvidia highlighted Stereotaxis’ efforts to incorporate AI into its robotics platform. Meanwhile, its Connect program supports member companies with its software development resources, industry-leading frameworks and software development kits.
St. Louis-based Stereotaxis’ surgical robotics reach spans more than 100 leading hospitals and more than 150,000 patients. Its Genesis robotic magnetic navigation (RNM) system delivers the benefits of robotic precision and safety to cardiac ablation to treat arrhythmias. The system utilizes smaller magnets that rotate along their center of mass, allowing for responsiveness to physician control. Flexible, rugged robotic arms hold the agents to increase the potential range of motion and allow for wider X-ray angulation.
The company says it has its sights on the next phase of technological progress, focusing on digital solutions to enhance its robotic systems. That includes investment in AI, robotic automation, data integration and decision support capabilities.
“We greatly appreciate the support of Nvidia in our efforts to pioneer endovascular robotics and take the technology to new incredible heights,” said David Fischel, Stereotaxis chair & CEO. “The combination of robotics’ mechanistic benefits – precision, safety, stability – with the promise of AI innovations will dramatically transform what is possible in treating patients. We are excited for the path ahead of us.”
